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In Brief Boal et al. show that Shigella's metaeffector IpgD triggers, via PI5P production, the internalization and degradation of the adhesion molecule ICAM-1 in infected intestinal cells, thereby reducing neutrophil recruitment both in vitro and in vivo. Their results uncover a strategy of immune evasion used by this pathogen.
INTRODUCTION
Phosphoinositides are key regulators of many aspects of cellular functions controlling signal transduction pathways, cytoskeleton remodeling, and vesicular trafficking (Di Paolo and De Camilli, 2006) . Among the phosphoinositides family, phosphatidylinositol 5-phosphate (PI5P) is one of the least characterized members in mammalian cells (Rameh et al., 1997) . Although PI5P functions are not fully revealed, it is now considered a nuclear stress sensor and a regulator of membrane dynamics (Viaud et al., 2014) . The lipid is present in low basal amounts in resting cells and increases upon agonist stimulation (Morris et al., 2000) and stress conditions such as osmotic shock or UV radiation (Jones et al., 2006; Sbrissa et al., 2002) . A robust increase in PI5P is also observed during infection with the Gram-negative bacterium Shigella flexneri (Niebuhr et al., 2002) . In this context, PI5P is produced by IpgD, one of the virulence factors injected by the type III secretion system, a syringe-like complex that transfers bacterial proteins directly into host cells (Puhar and Sansonetti, 2014) . IpgD is a phosphatidylinositol 4-phosphatase specifically hydrolyzing PI(4,5)P 2 to generate PI5P (Niebuhr et al., 2002) . We have previously shown that PI5P is a key regulator of the trafficking of the epidermal growth factor receptor (EGFR). Indeed, PI5P activates the EGFR in a ligand-independent manner at the plasma membrane (Ramel et al., 2011) and delays its degradation through the recruitment of the adaptor TOM1 to signaling endosomes (Boal et al., 2015) , thereby leading to prolonged PI3K-Akt survival signals in Shigella-infected cells (Pendaries et al., 2006) .
Shigella flexneri is the causative agent of bacillary dysentery in humans. After its passage from the intestinal lumen to the mucosa via M-cells, Shigella invades epithelial cells, triggering production of proinflammatory cytokines and chemokines, resulting in strong inflammation (Phalipon and Sansonetti, 2007) . Indeed, infection of epithelial cells activates the cytoplasmic peptidoglycan sensors Nod1 and 2, which stimulate NF-kB, the master regulator of proinflammatory cytokine production (Girardin et al., 2003a (Girardin et al., , 2003b . Moreover, infected epithelial cells secrete the endogenous danger signal ATP as an early alert response acting upstream of proinflammatory cytokines (Puhar et al., 2013) . However, Shigella has also evolved to control inflammation. To achieve this, the bacteria have developed an array of strategies involving different effectors encoded on their large virulence plasmid and delivered by the type III secretion system (Phalipon and Sansonetti, 2007) . Many effectors prevent NF-kB activation by altering welldescribed pathways such as ubiquitin-dependent protein degradation and MAPK signaling. These effectors include OspG (Kim et al., 2005) , OspF (Arbibe et al., 2007; Li et al., 2007) , IpaH9.8 (Ashida et al., 2007 (Ashida et al., , 2010 Rohde et al., 2007) , OspZ (Newton et al., 2010) , and OspI (Sanada et al., 2012) . Shigella also modulates inflammation by inhibition of host sphingosine-1-phosphate levels (Kim et al., 2014) . Recently, we showed that the effector IpgD, through the production of PI5P, is able to dampen inflammation through the inhibition of ATP secretion (Puhar et al., 2013) .
After infection, the inflammatory response is immediately initiated by the activation of the innate immune system. Neutrophils are the primary immune cells observed at sites of infection and are involved in the pathogenesis of shigellosis in humans and monkeys (Parsot and Sansonetti, 1996) . In the rabbit ileal loop model, Shigella infection is characterized by a massive recruitment of neutrophils to the mucosa because of the production of IL-8 by intestinal epithelial cells (Sansonetti et al., 1999) . Neutrophils migrate across the epithelium, a process called transmigration that involves several subsequent steps: adhesion to the basolateral surface, crossing of the epithelial layer, and adhesion to the apical side (Fournier and Parkos, 2012) .
ICAM-1 (intercellular adhesion molecule-1) is a cell surface glycoprotein member of the immunoglobulin superfamily that is essential to cell-to-cell adhesion and activation of signaling pathways in response to inflammation (Lawson and Wolf, 2009 ). ICAM-1 expression is increased in epithelial cells in response to inflammatory cytokines such as interferon gamma and tumor necrosis factor alpha (TNF-a) (Dippold et al., 1993) . In patients with inflammatory bowel disease and during bacterial infection, a raise in expression of the receptor is also observed (Dippold et al., 1993; Huang et al., 1996) . In intestinal epithelial cells, ICAM-1 is the major leukocyte receptor. Its expression is restricted to the apical side (Huang et al., 1996) , where it facilitates the adhesion of neutrophils that have reached the intestinal lumen (Parkos et al., 1996) . Engagement of ICAM-1 by the leukocyte B2-integrins Mac-1 and LFA-1 triggers intracellular signaling pathways (Holland and Owens, 1997) , which are still not fully characterized (Hubbard and Rothlein, 2000) .
We have previously demonstrated that PI5P produced by IpgD was able to trigger the internalization of the EGFR (Boal et al., 2015; Ramel et al., 2011) . It was therefore tempting to speculate that Shigella could subvert the subcellular trafficking of cell surface receptors involved in inflammation such as ICAM-1 to escape the immune response. In this study, we show that IpgD induces the internalization of ICAM-1 and directs it to the lysosomal degradation pathway in HT-29 colorectal epithelial cells. ICAM-1 internalization to a late endosomal compartment is PI5P dependent, as confirmed by the use of cell permeant lipids, and does not involve the PI3-kinase pathway. In addition, we demonstrate that PI5P reduces the adhesion of human neutrophils to epithelial cells in vitro. Finally, using the rabbit ileal loop model of Shigella infection, we confirm that IpgD reduces neutrophil recruitment to the intestinal lumen. Altogether, our results establish a mechanism of immune evasion involving the lipid PI5P produced by the Shigella effector IpgD to control the cell surface exposure of a receptor that is essential to the inflammatory response.
RESULTS

Increased PI5P Levels Induce ICAM-1 Internalization
We previously demonstrated that in human epithelial HeLa cells PI5P produced by IpgD expression induced EGF receptor activation, its internalization to early endosomes, and a sustained activation of the PI3K-Akt survival pathway (Ramel et al., 2011) . We therefore explored whether the recycling of cell surface receptors involved in inflammation pathways could also be affected by IpgD, thereby strengthening the anti-inflammatory effect of Shigella. To investigate whether Shigella infection could induce ICAM-1 internalization in HT-29 cells, we conducted a pilot experiment in which we infected the cells with different Shigella strains and monitored its localization by immunofluorescence on fixed cells. As a control, we quantified the internalization of EGFR, which we previously demonstrated to be internalized in an IpgD-dependent manner (Ramel et al., 2011) . The results, shown in Table 1 , indicated that Shigella infection induced EGFR internalization in HT-29 cells. Similarly, in cells infected with the WT strain, we measured an increase in ICAM-1 internalization. This internalization was neither observed in cells infected with non-invasive mutant (DmxiD) nor in cells infected with the ipgD-deficient strain (DipgD).
These results strongly suggested that ICAM-1 was internalized in cells infected by Shigella through an IpgD-dependent mechanism. In order to confirm this, we transiently expressed GFP-IpgD in HT-29 cells. In GFP-expressing control cells, ICAM-1 showed a plasma membrane localization, with no or little intracellular staining (Figures 1A and 1B, GFP panel) . Strikingly, in IpgD-expressing cells, ICAM-1 was internalized (Figures 1A and 1B, IpgD panel) . Overexpression of phosphatase-inactive IpgD owing to a single point mutation at the catalytic site (IpgD-CS) (Niebuhr et al., 2002) did not induce ICAM-1 internalization (Figures 1A and 1B, , suggesting that this internalization could depend on PI5P synthesis. As a control, ectopic expression of the heterologous phosphatase Inp54p, known to transform PI(4,5)P 2 into PI4P (Raucher et al., 2000) , was used. As shown in Figure S1 , Inp54p expression had no effect on ICAM-1 localization, suggesting that PI5P synthesis rather than changes in PI(4,5)P 2 levels could account for ICAM-1 internalization in IpgD-expressing cells.
ICAM-1 Is Internalized to the Endo-lysosomal Compartment
To identify the subcellular compartment in which ICAM-1 was localized following its internalization, we resorted to immunofluorescence on fixed HT-29 cells. As shown in Figures 2A and 2B , internalized ICAM-1 in IpgD-expressing cells did not co-localize with EEA1 (a bona fide marker for early endosomes) or with APPL1 (a marker for signaling endosomes). In contrast, ICAM-1 was internalized in a LAMP-2-positive compartment, as illustrated by the increase in the Pearson's coefficient ( Figure 2B ). Remarkably, IpgD expression in HT-29 cells, which induced Akt activation through EGFR ( Figure S2A ), resulted in EGFR accumulation in EEA1-positive early endosomes ( Figures S2B-S2D ), as we previously described in other cell types (Boal et al., 2015; Ramel et al., 2011) . Similar to IpgD overexpression, we found that cells infected by WT Shigella showed a dramatic internalization of ICAM-1 (Figure 2C) , with an increase in co-localization with LAMP2 (Figure 2D ). This phenomenon was dependent on the effector IpgD, as shown by the lack of effect of the DipgD strain ( Figures  2C and 2D) .
Addition of short-chain cell permeant PI5P provided a quick and synchronized stimulatory pulse that mimics IpgD overexpression (Boal et al., 2015; Ramel et al., 2011) . We previously showed that incubation of cells with cell-permeant PI5P induced activation of the EGFR-PI3K-Akt signaling pathway in HeLa cells (Pendaries et al., 2006; Ramel et al., 2011) . In HT-29 cells, incubation with short chain PI5P resulted in a marked internalization of EGFR ( Figure S3 ). Strikingly, treatment of HT-29 cells with permeant PI5P, but not PI4P, resulted in the internalization of ICAM-1 ( Figures 3A, 3B , S4A, and S4B). Internalized ICAM-1 in PI5P-treated cells co-localized with the late endosomal marker LAMP2 ( Figure S4C ). Furthermore, the use of permeant PI5P allowed us to confirm ICAM-1 internalization using an acid-wash removal of surface-bound anti-ICAM-1 antibodies. Indeed, as shown in Figures 3C and 3D , a strong signal for internalized ICAM-1 was observed in only PI5P-treated cells.
Interestingly, EGFR did not co-localize with internalized ICAM-1 in PI5P-treated cells ( Figure 3E ). This clearly demonstrated that the two receptors were internalized to distinct populations of endosomes, EGFR being internalized into an early compartment (EEA1 positive), while ICAM-1 to a later compartment (LAMP2 positive).
The fact that internalized ICAM-1 co-localized with the late endosome/lysosome marker LAMP2 suggests that IpgD induced a disappearance of ICAM-1 from the cell surface to the degradative pathway.
PI5P Induces ICAM-1 Degradation
In HT-29 cells, only very low transfection rates of IpgD could be achieved (data not shown). For this reason, we used MEF cells stably expressing IpgD under the control of an inducible Tet-OFF promoter. In these cells, transiently overexpressed GFP-ICAM-1 was internalized in a PI5P-dependent manner (Figures 4A and 4B) . We then asked the question of whether ICAM-1 internalization was a specific event or a feature that could be generalized to several other cell adhesion molecules or receptors. To this end, we overexpressed GFP-fused endothelial-specific adhesion molecule VCAM-1 or the purinergic G-proteincoupled receptor P2Y 12 . As shown in Figure 4C , IpgD expression did not alter the plasma membrane localization of these receptors, suggesting a selectivity in receptor endocytosis driven by PI5P.
Next, we performed EM analysis of ICAM-1 localization in MEF cells stably expressing IpgD versus control cells. Immunogold labeling of cryosections showed that the majority of GFP-ICAM-1 was found on intracellular vesicles in IpgD-expressing cells (Figures 4D and 4E, ICV) , while in control cells, it was mainly found at the plasma membrane (Figures 4D and 4E, PM) .
Finally, immunoblotting and quantification of GFP-ICAM-1 clearly demonstrated that it was degraded in IpgD-expressing cells while no change in its mRNA level was observed ( Figures  4F-4H ). Moreover, treatment of cells with the lysosomal inhibitor bafilomycin A1 totally abrogated ICAM-1 degradation. Overall, our results showed that PI5P produced by IpgD was responsible for the internalization and degradation of the cell adhesion molecule ICAM-1 in lysosomes.
PI5P Reduces Neutrophil Adhesion to HT-29 Cells
Cell-surface-exposed ICAM-1 binds to the leukocyte integrins LFA-1 and MAC-1 (Lawson and Wolf, 2009 ) and has been shown to be involved in the recruitment of neutrophils to the site of infection (Huang et al., 1996) . As PI5P induced ICAM-1 internalization and degradation, we hypothesized that it could impact on the inflammatory response by reducing neutrophil recruitment. Using purified human neutrophils stained with the viability dye DiOC6(3) in a cell-cell adhesion assay, we showed that PI5P, but not PI4P treatment, significantly reduced neutrophil adhesion in a similar extent to the blocking anti-ICAM-1 antibody (Figures 5A and 5B).
IpgD-Dependent Transepithelial Migration of Neutrophils In Vivo
In order to support our results in vivo, we infected rabbit ileal loops with the WT Shigella strain and the ipgD-deficient strain. We performed immunofluorescence stainings on fixed samples of infected tissues. Cohesion of the epithelial lining was evaluated based on the regular and linear position of DAPI-stained nuclei. As shown in Figure 6A , ICAM-1 localization was altered in infected epithelial cells in an IpgDdependent manner. Indeed, juxtanuclear accumulation of ICAM-1 was only observed after infection with the WT strain but not with the ipgD-deficient mutant, while no change in ICAM-1 expression levels was detected (Table S1) .
Next, we evaluated the transmigration of neutrophils. As shown in Figure 6B , in tissues infected by the WT strain, a large amount of bacteria was seen on the surface of the epithelium at this time of incubation. In parallel, neutrophils remained essentially located in the connective tissue of the villi lamina propria. Few were seen associated to the epithelial lining and the bacteria in the gut lumen. Conversely, in tissues infected with the ipgD-deficient strain, bacteria were still at this stage essentially located luminally on the epithelial surface, but neutrophils were largely seen associated with the epithelial lining and mixed with bacteria in the lumen ( Figure 6B , DipgD). Quantification of neutrophil localization confirmed their inability to cross the epithelial lining ( Figure 6B, right) .
Altogether, these results suggest that Shigella, through the injection of IpgD, induces a decrease in neutrophil recruitment to the apical side of the epithelial cells by reducing ICAM-1 cell surface localization, ultimately leading to the inhibition of their transmigration.
DISCUSSION
Taken together, our results demonstrate that the virulence factor IpgD is able to alter the subcellular trafficking of the inflammatory receptor ICAM-1 in Shigella-infected epithelial cells. High levels of IpgD-produced PI5P are responsible for the internalization of ICAM-1 and its subsequent degradation, reducing neutrophil adhesion and providing the bacteria with a way to dampen immune cell recruitment.
In this study, we show that high levels of PI5P induced internalization of specific cell adhesion molecules (such as ICAM-1 but not VCAM-1) or receptors (such as EGFR but not P2Y 12 ). This could be due to specific endocytic machineries activated by PI5P. To date, a broad variety of endocytic routes has been described (Doherty and McMahon, 2009) , in particular regarding ICAM-1 endocytosis (Stan, 2006) . Engagement of ICAM-1 by leucocytes on endothelial cells induces ICAM-1 clusterization and internalization in a caveolin-1 dependent mechanism (Millá n et al., 2006) . Other studies showed that ICAM-1 internalization induced by multivalent antibodies is molecularly distinct, involving dynamin-2 but not clathrin or caveolae (Muro et al., 2003 (Muro et al., , 2006 . Using selective inhibitors, we could rule out the involvement of the EGFR-PIK3-Akt pathway as well as the GTPase dynamin in PI5P-dependent ICAM-1 internalization ( Figure S5 ). Therefore, this process is molecularly distinct from the previously described ICAM-1 internalization induced by nanoparticlecoupled antibodies, called CAM-endocytosis (Muro et al., 2003) , and will require subsequent studies to be fully characterized. Interestingly, PI5P differentially mediates the trafficking of EGFR and ICAM-1 in the very same cells. Indeed, while elevated PI5P levels induce an accumulation of EGFR in the early endosomes, ICAM-1 traffics through a later compartment and is ultimately degraded. This discrepancy could be due to specificity in cargo sorting from the endosomal compartment. We recently demonstrated that the endosomal protein TOM1 is enriched on endosomes in IpgD-expressing cells and that this accumulation is responsible for the stalling of EGFR (Boal et al., 2015) . However, although TOM1 accumulation blocks EGFR trafficking in early endosomes, ICAM-1 is degraded in lysosomes, indicating that a different effector may account for ICAM-1 specific cargo sorting. Identification of this putative effector will be of great interest to gain insight into the molecular mechanisms involved in Shigella-induced ICAM-1 trafficking.
ICAM-1 is a key molecule mediating the recruitment of neutrophil on the apical side of the epithelium. In our study, we show that PI5P reduces neutrophil adhesion in vitro, while in the in vivo intestinal loop model, we observed a dramatic reduction in neutrophil transepithelial migration. Sumagin et al. (2014) have demonstrated that engagement of epithelial ICAM-1 at the apical face results in an increase in epithelium permeability through the activation of the myosine light chain kinase MLCK. Furthermore, Millá n et al. (2006) have demonstrated that neutrophil adhesion on the apical face will trigger the transcytosis of ICAM-1 to the basal face. Altogether, this will facilitate subsequent neutrophil transmigration from the basal to apical face of the epithelium. Our in vivo observations are in line with these concepts, as adhesion to the apical face and transmigration are intimately linked.
Shigella flexneri is using distinct and complex pathways to dampen the host cell inflammatory response to its own advantage. To achieve this, the bacteria combine the activity of different effectors injected from the early stage of the infectious process. These effectors essentially target the NF-kB pathway, ultimately controlling the production of pro-inflammatory cytokines (Arbibe et al., 2007; Ashida et al., 2007 Ashida et al., , 2010 Kim et al., 2005; Li et al., 2007; Newton et al., 2010; Rohde et al., 2007; Sanada et al., 2012) . Shigella also modulates inflammation by inhibiting the host sphingosine-1-phosphate levels providing the first example for the role of a lipid mediator in regulating inflammation response (Kim et al., 2014) . Strikingly, in the case of IpgD, the same effector targets multiple pathways to dampen the host inflammatory response during infection. In addition to affecting T cell migration (Konradt et al., 2011) , we recently showed that IpgD, through the production of PI5P blocks connexin-mediated secretion of the endogenous danger signal ATP by epithelial cells, leading to immune evasion (Puhar et al., 2013) . In this paper, we unveil a third way used by IpgD to dampen the inflammatory response by targeting the cell surface adhesion molecule ICAM-1 receptor, thus making this phosphoinositide phosphatase a bona fide meta-effector. Although blockade of ICAM-1 with antibodies has been shown to be beneficial in several inflammatory diseases, such as in polymicrobial sepsis (Zhao et al., 2014) or in Crohn's disease (in combination with anti-VCAM-1 antibodies) (Burns et al., 2001) , our study shows that this defense mechanism is hijacked by Shigella for its own benefit.
We describe here a bacterial strategy of evasion to immune responses involving the direct alteration of the trafficking of ICAM-1, thereby leading to its disappearance from the cell surface. Such a mechanism has so far only been described in a few cases of viral infection. For instance, a decrease of ICAM-1 expression has been reported in keratinocytes after infection by the varicella zoster virus (Nikkels et al., 2004) , and infection with the Kaposi sarcoma-associated herpes virus was shown to lead to downregulation of ICAM-1 cell surface expression through an E3 ubiquitin ligase encoded by the virus (Brulois et al., 2014; Tomescu et al., 2003) .
In conclusion, we outline an original strategy used by the bacteria to subvert the subcellular trafficking of the cell surface adhesion molecule ICAM-1, thereby reducing the recruitment of neutrophils, the primary immune cells recruited to site of inflammation. Finally, our data reinforce the key role of the lipid mediator PI5P in the control of several main cellular functions and provide a potential new anti-inflammatory target.
EXPERIMENTAL PROCEDURES Materials
Antibodies used in this study are as follows: anti-Akt (clone H-136, sc-8312, Santa Cruz Biotechnology), anti-pAkt (S473; clone D9E, #4060, Cell Signaling), anti-LAMP2 (ab13524, Abcam), anti-APPL1 (D83H4, Cell Signaling), antipEGFR (Y1173; sc-12351-R, Santa Cruz Biotechnology), anti-Ly-6B.2 (AbD Serotec). Antibodies against EGFR were from BD Biosciences (#555996) or from Cell Signaling (clone D38B1, #4267). Mouse antibody against EEA1 was from BD Biosciences (#610457); rabbit antibody against EEA1 was from Enzo Life Sciences (#ALX-210-239-C100). Anti-ICAM-1 antibodies were from Abcam (ab33090) or from Santa Cruz Biotechnology (sc-18853). Secondary HRP-coupled antibodies were from Promega. Alexa Fluor-coupled antibodies were from Life Technologies. The peGFP-N1-ICAM-1 and VCAM-1 were kindly provided by Dr. Francisco Sanchez-Madrid (CNIC) and was as described (Barreiro et al., 2002) . P2Y 12 -GFP plasmid was provided by Dr. Veronique Pons and was as described (Pons et al., 2014) . Other chemicals were from SigmaAldrich. qRT-PCR analysis was performed as described (Boal et al., 2015) .
Cell Culture, Transfections, and Induction of ICAM-1 Expression
The human colorectal epithelial cell line HT-29 and MEF cells were grown in DMEM (#31966-021, Life Technologies) supplemented with 10% fetal bovine serum (FBS). ICAM-1 expression was induced by stimulation with TNF-a (50 ng/ml) overnight. HT-29 cells were transfected using jetPRIME (Polyplus transfection) according to manufacturer's instructions. When needed, the cells were serum starved for at least 3 hr before being processed. Mouse embryonic fibroblast (MEF) cells stably expressing IpgD under the control of a Tet-OFF promoter were as described (Boal et al., 2015) .
Immunofluorescence and Quantification of Internalization of EGFR or ICAM-1
Immunofluorescence was performed essentially as described (Boal et al., 2010) . Briefly, cells grown on glass coverslips were PFA fixed, followed by permeabilization with 0.1% Triton X-100 in PBS for 5 min, blocked using PBS containing 1% BSA (PBS-BSA) and probed with primary antibodies followed by secondary antibodies. Coverslips were mounted in Mowiol and imaged by confocal microscopy on a LSM510 or LSM780 confocal microscope (Zeiss), and the imaging parameters were set to prevent any saturation of the signals. For co-localization studies, Pearson's coefficient was calculated using the Colocalization Threshold plugin in ImageJ. For quantification of internalized EGFR or ICAM-1, an outer ring just surrounding the cell was drawn, which yielded the total fluorescence intensity, i.e., the total amount of EGFR or ICAM-1 expressed in the cell. An inner ring just below the plasma membrane was then drawn, which yielded the amount of EGFR or ICAM-1 internalized into the cell. The ratio between the two values gave the amount of internalized EGFR or ICAM-1, normalized against the total amount of receptor expressed in the cell and was expressed as percentage of the control.
Western Blotting
Typically, cells were washed in ice-cold PBS and lysed in buffer (50 mM Tris [pH 7.5], 150 mM NaCl, 1% Triton X-100, 1 mM EDTA, 1 mM orthovanadate sodium, 50 mM beta-glycero phosphate, protease inhibitor Cocktail Set V; Calbiochem) for 30 min on ice. Cell lysates were clarified by centrifugation at 10,000 3 g for 10 min at 4 C and quantified using Bio-Rad protein assay.
Lysates were denaturated in Laemmli sample buffer, and proteins were separated by SDS-PAGE before western blotting on Immobilon-P membranes (Merck-Millipore). Immunoreactive bands were detected by chemiluminescence with the SuperSignal West Pico detection system (Thermo Scientific) on a ChemiDoc MP acquisition system (Bio-Rad). To detect ICAM-1 by western blot, samples were specifically resuspended in DTT-free Laemmli buffer.
Short-Chain Cell Permeant Phosphoinositides Treatments and Internalization Assay
HT-29 cells grown on glass coverslips were incubated with 15 mM C4-PI4P or C4-PI5P (Echelon Biosciences) for the indicated times as previously described (Pendaries et al., 2006; Ramel et al., 2011) before being processed for immunofluorescence or western blot. For internalization assay, cells were surface labeled with an anti-ICAM-1 antibody for 30 min at 4 C and washed with ice-cold PBS. Internalization of bound antibodies was performed at 37 C for 30 min in the presence or not of permeant PI5P. Surface-bound antibodies were stripped by acid wash (25 mM glycine, 3% BSA in PBS [pH 3]) for 10 min on ice. After extensive washes, the cells were PFA fixed, stained with a fluorescent anti-mouse antibody, and imaged by confocal microscopy.
In Vitro Neutrophil Adhesion Assay
Neutrophil adhesion assays were essentially performed as described elsewhere (Huang et al., 1996) . Briefly, buffy coat obtained from healthy donors was mixed with an equal volume of 6% dextran-500 in PBS and incubated at room temperature for 40 min. The top layer (leukocyte rich plasma) was then recovered, and cells were washed in PBS. Residual erythrocytes were lysed by a 5-min incubation at room temperature in ACK lysis buffer (0.15 M NH 4 Cl, 1 mM KHCO 3 , 0.1 mM EDTA [pH 7.3]). After washing, the remaining white blood cells were layered on Ficoll-Plaque Plus (GE Healthcare) and centrifuged for 40 min at 400 3 g at room temperature. The pellet was harvested, and obtained neutrophils were washed in PBS. Neutrophils were stained with the viability dye DiOC6(3) (Life Technologies) for 10 min at 37 C at 500 nM. For adhesion assays, HT-29 cells grown to confluency in 48-well plates were stimulated overnight with TNF-a (50 ng/ml) and treated accordingly with permeant C4-PI4P or C4-PI5P for 30 min at 37 C. Alternatively, cells were treated with 10 ml per well of the blocking anti-ICAM-1 antibody (ab33090) for the same time. Stained neutrophils were then added (90,000 cells per well), and the plate was centrifuged at room temperature for 5 min at 50 3 g. After incubation for 10 min at 37 C, the cells were extensively washed in PBS, and live cell imaging was performed to visualize adherent neutrophils. For quantifications, three random fields of view were imaged using a wide-field fluorescent microscope equipped with a 43 lens. Same imaging parameters were used to compare the different conditions. After thresholding, the mean fluorescence intensity per field of view was quantified using ImageJ, and results were expressed as mean ± SEM from four independent experiments and presented as a percentage of the untreated control. 
Shigella Flexneri Strains and In Vitro and In Vivo Infections
The WT Shigella flexneri serotype 5a strain M90T, the non-invasive DmxiD mutant and the DipgD mutant were described previously (Puhar et al., 2013) . Infections of rabbit ileal loops or HT-29 cells were also performed as described (Puhar et al., 2013) . Analysis of ICAM-1 expression from ligated ileal loops was performed as described (Puhar et al., 2013) . Primers used are as follows: 5 0 -AACTCTTGACTTGGATGTATT-3 0 (sense) and 5 0 -GCAGGAACCTACTC TACT-3 0 (antisense).
Immunofluorescence on Paraffin-Embedded Sections
Paraffin-embedded ileal loop sections were deparaffinized and rehydrated, and antigen retrieval was performed using a sodium citrate treatment (15-min incubation in a 70 C water bath). For ICAM-1 staining, a gentler sodium citrate treatment was performed (2-min incubation in a 70 C hot water bath). Permeabilization was performed with 0.2% Triton X-100 for 20 min. After blocking of nonspecific sites with 1% BSA, the primary antibodies were incubated overnight at 4 C. After labeling with appropriate secondary antibodies, the sections were mounted in Vectashield mounting medium, including DAPI (Vector Laboratories), and imaged by epifluorescence microscopy.
Immunoelectron Microscopy
For immunoelectron microscopy, samples were fixed with a mixture of 2% PFA and 0.2% glutaraldehyde in 0.1 M phosphate buffer (pH 7.4). Cells were scraped, pelleted, and embedded in 10% bovine skin gelatin in 0.1 M phosphate buffer. Fragments of the pellet were infiltrated overnight with 2.3 M sucrose in 0.1 M phosphate buffer at 4 C, mounted on aluminum studs, and frozen in liquid nitrogen. Sectioning was done at À120 C in a cryoultramicrotome (UC7/FC7 Leica Microsystems). The 80-nm ultrathin sections were collected in 1:1 mixture of 2.3 M sucrose and 2% methyl cellulose and transferred onto Formvar-carbon-coated nickel grids for immunogold localization. Cells were immunolabeled with anti-ICAM-1 and immunogold-labeled using 10 nm protein A-gold particles. Grids were then stained with a mixture of 2% methylcellulose and 0.4% uranyl acetate. Samples were analyzed with a TEM (Jeol JEM-1400, JEOL) at 80 kV. Images were acquired using a digital camera (Gatan Orius, Gatan) at 10,0003 magnification. (A) HT-29 cells seeded on glass coverslips were stimulated onvernight by TNF (50ng/ml), and were transiently transfected for GFP, GFP-IpgD or GFP-Inp54p. 24h later, the cells were serum-starved for 3-5 hours, fixed, stained for endogenous ICAM-1 (red in merge) and imaged by confocal microscopy. Bar is 10µm. HT-29 cells were seeded on glass coverslips, serum starved and treated for the indicated times (min) with permeant PI4P or PI5P. Cells were then fixed, stained for EGFR and imaged by confocal microscopy.
Statistical Analysis
Internalization of EGFR was quantified as in figure 3 . Results are shown as mean+/-SE. Bonferroni's multiple comparison test, p value is indicated on the graph, ns, non-significant. HT-29 cells seeded on coverslips were serum-starved for 2h, pretreated for 1h with either AG1478 (EGFR inhibitor), AG1296 (PDGFR inhibitor), PI3-kinase inhibitor (LY294002) or the dynamin inhibitor Dynasore (80µM) and then stimulated with 15µM permeant PI5P in the continuous presence of the chemicals for 30min.
The cells were then fixed and stained to localize endogenous ICAM-1. Control untreated cells are shown as comparison (NT). Bar is 10µm. Ligated ileal loops of rabbits were infected for 5h with the indicated Shigella strains and RT-qPCR were performed to quantify the expression level of ICAM-1. The mean of duplicate loops with range of expression is given with respect to tissue infected with the mxiD-deficient strain for two rabbits.
